Spherix is currently seeking partners along two business fronts:

• Formulations – Spherix is interested in forming alliances with pharmaceutical companies in need of unique formulation development for new or existing therapeutics.
• Drug Development – Spherix is seeking to in-license pre-clinical or clinical candidates that fit with its existing model of developing natural compounds produced by synthetic processes.

Spherix is looking to attract partners wishing to expand their formulation and development capabilities by out-licensing candidates, thus providing funding to the partner and lowering commercial risk.

Please contact business@biospherics.com with Business Development inquiries or call Robert Lodder at 301-476-0705.